Cardiovascular effects of SL65.0472, a 5-HT receptor antagonist

European Journal of Pharmacology

Volumn 414, Issue 2-3, 2001, Pages 259-269

  O'Connor, Stephen E ^a   Grosset, Alain ^a   Drieu La Rochelle, Christophe ^a   Gautier, Etienne ^a   Bidouard, Jean Pierre ^a   Robineau, Pascale ^a   Caille, Dominique ^a   Janiak, Philip ^a  

^a SANOFI   (France)

Author keywords

5 HT1B receptors; 5 HT2A receptors; Haemodynamics; SL 65.0472

Indexed keywords

7 FLUORO 2 OXO 4 [2 [4 (THIENO[3,2 C]PYRIDIN 4 YL)PIPERAZIN 1 YL]ETHYL] 1,2 DIHYDROQUINOLINE 1 ACETAMIDE; DIHYDROQUINOLINE DERIVATIVE; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE; SEROTONIN 1B ANTAGONIST; SEROTONIN 1B RECEPTOR; SEROTONIN 2A ANTAGONIST; SEROTONIN 2A RECEPTOR; SL 650472; SUMATRIPTAN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW; CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; DOG; DRUG EFFECT; DRUG SCREENING; ELECTROCARDIOGRAM; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; HEART RATE; HEMODYNAMICS; HYPERTENSION; LUNG PRESSURE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; SAPHENOUS VEIN; SPINAL ANIMAL; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR RESISTANCE; VASOCONSTRICTION;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DOGS; HEART RATE; HEMODYNAMIC PROCESSES; MALE; PIPERAZINES; PRAZOSIN; QUINOLINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN ANTAGONISTS; SUMATRIPTAN; VASOCONSTRICTOR AGENTS;

EID: 0035794012     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(01)00804-4     Document Type: Article

References (33)

1. Antiplatelet and oral antithrombotic activity of SL 65.0472
2. 1-like receptors revealed by precontraction of rabbit isolated mesenteric artery
3. 1D antagonists
4. LY53857, a selective and potent 5-HT receptor antagonist, does not lower blood pressure in the spontaneously hypertensive rat
5. 1-like receptors in the reduction of porcine cranial arteriovenous anastomotic shunting by sumatriptan
6. 1D receptor antagonist
7. 1-like receptor activation
8. The selective carotid arterial vasoconstrictor action of GR 43175 in anaesthetized dogs
9. Mechanism of the hypotensive effect of ketanserin
10. Effects of SL 65.0472, a novel 5-HT receptor antagonist on 5-HT receptor mediated vascular contraction
11. Local effect of serotonin released during coronary angioplasty
12. 1B receptor
13. 1D receptor subtypes
14. 5-Hydroxytryptamine stimulation of phospholipase D activity in the rabbit isolated mesenteric artery
15. 1-like receptor in dog isolated saphenous vein
16. 2 receptors in serotonin-induced contraction of human isolated coronary arteries
17. 1-receptor agonist on central haemodynamics and the coronary circulation
18. 1 agonist, on the systemic, pulmonary and coronary circulation
19. 1-like receptor-mediated vasoconstriction in human pulmonary artery
20. Cardiac electrophysiologic effects of intravenous ketanserin in humans
21. Characterisation of 5-HT receptors in human coronary artery by molecular and pharmacological techniques
22. 2A receptor antagonist properties of SL 65.0472 in vivo
23. 1-like receptors mediate 5-HT-induced contraction of human isolated basilar artery
24. Antihypertensive mechanism of action of ketanserin and some ketanserin analogues in the spontaneously hypertensive rat
25. Prevention of atherosclerotic complications: Controlled trial of ketanserin
26. Cardiovascular effects of serotonin agonists and antagonists
27. 1Dα receptor subtype expression in canine large coronary arteries and saphenous vein
28. 2 serotonergic receptors
29. 1B receptor-mediated contractions of human temporal artery: Evidence from selective antagonists and 5-HT receptor mRNA expression
30. Serotonin is associated with coronary artery disease and cardiac events
31. 1Dβ receptors
32. Electrophysiologic effects of ketanserin on canine Purkinje fibers, ventricular myocardium and the intact heart
33. 1Dβ receptor subtypes